SCHEMBL1741902

SCHEMBL1741902

CC(C)(C)OC(=O)NC(C=CC(=O)O)C(O[Si](C)(C)C(C)(C)C)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 3/20 0.41
PPARG P37231 2/20 0.41
GABRB1 P18505 1/20 0.32
GABRB2 P47870 1/20 0.32
CTSS P25774 1/20 0.31
CTSK P43235 1/20 0.31
CNR2 P34972 1/20 0.31
MAPT P10636 2/20 0.31
ATM Q13315 1/20 0.31
AAK1 Q2M2I8 1/20 0.31
TSHR P16473 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
PDE2A O00408 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
NR4A1 P22736 1/20 0.30
NR4A2 P43354 1/20 0.30
NR4A3 Q92570 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1741901 1.00 PPARA (0.41) PPARAPPARGGABRB1GABRB2CTSS
SCHEMBL12241676 0.91 PPARG (0.38) PPARAPPARGGABRB1GABRB2CTSS
SCHEMBL1743516 0.91 PPARG (0.38) PPARAPPARGGABRB1GABRB2CTSS
SCHEMBL1743514 0.91 PPARG (0.38) PPARAPPARGGABRB1GABRB2CTSS
SCHEMBL1743518 0.91 PPARG (0.38) PPARAPPARGGABRB1GABRB2CTSS
SCHEMBL1742741 0.82 PPARG (0.44) PPARAPPARGGABRB1GABRB2CTSS
SCHEMBL1595742 0.82 PPARG (0.44) PPARAPPARGGABRB1GABRB2CTSS
SCHEMBL5019017 0.82 PPARG (0.44) PPARAPPARGGABRB1GABRB2CTSS
SCHEMBL12706285 0.82 PPARG (0.41) PPARAPPARGGABRB1GABRB2PDE2A
SCHEMBL1742052 0.79 PPARG (0.39) PPARAPPARGCTSSCTSKAAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387570-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE Amgen, Inc (US) 2011-11-23 EP disclosed
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2011-10-27 US disclosed
WO-2010083246-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE TFEB, PCK2, JAK2 PPARA 896/4885PPARG 232/4885GABRB1 3331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.